- Trials with a EudraCT protocol (27)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (3)
27 result(s) found for: Compensation.
Displaying page 1 of 2.
EudraCT Number: 2017-001019-35 | Sponsor Protocol Number: D16-P15 | Start Date*: 2017-12-19 |
Sponsor Name:Centre Hospitalier Sainte-Anne | ||
Full Title: Effect of vitamin D deficiency compensation in the treatment of drug-resistant epilepsy. | ||
Medical condition: Patients suffering from drug-resistant epilepsy. | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2018-002474-52 | Sponsor Protocol Number: AM-125-CL-18-01 | Start Date*: 2019-04-01 | |||||||||||
Sponsor Name:Auris Medical AG | |||||||||||||
Full Title: Multicenter randomized controlled phase 2 trial to evaluate AM-125 in the treatment of acute peripheral vertigo following neurosurgery (TRAVERS) | |||||||||||||
Medical condition: Treatment of acute peripheral vertigo | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) CZ (Completed) PL (Completed) DE (Completed) GB (GB - no longer in EU/EEA) SK (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-003393-25 | Sponsor Protocol Number: LANTU_L_02673 | Start Date*: 2007-11-21 |
Sponsor Name:sanofi-aventis, s.r.o. | ||
Full Title: | ||
Medical condition: Type 2 diabetes mellitus | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: CZ (Completed) | ||
Trial results: View results |
EudraCT Number: 2010-019892-31 | Sponsor Protocol Number: 65759682 | Start Date*: 2011-06-15 | |||||||||||
Sponsor Name:Lightlake Sinclair Oy | |||||||||||||
Full Title: Hoitotutkimus BED-syömishäiriöstä ja sen taustatekijöistä | |||||||||||||
Medical condition: Binge Eating-Disorder, BED on ylipainoisilla esiintyvä syömishäiriö, jolle on luonteenomaista ahminta. Tutkimuksessa selvitetään nasaalisen (nenän kautta annosteltavan) naloksonilääkkeen tehoa BES ... | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-004636-66 | Sponsor Protocol Number: KP-2011-0077 | Start Date*: 2011-12-05 |
Sponsor Name:Uppsala University Hospital | ||
Full Title: Single-blinded randomized trial of Botulinumtoxin A (Vistabel®) and its objective paralytic effect in the facial muscles of healthy women: development of new neurophysiological measurements. | ||
Medical condition: The treatment of glabellar lines in healthy women by muscle paralysis from injection of botulinum toxin | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: SE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2010-024119-15 | Sponsor Protocol Number: rs4680-tolcapona | Start Date*: 2014-04-10 | |||||||||||
Sponsor Name:Clínica Universidad de Navarra/Universidad de Navarra | |||||||||||||
Full Title: EVALUATION OF THE EFFICACY OF TOLCAPONE AS A GENOTYPE-BASED TARGETED COGNITIVE ENHANCER IN SCHIZOPHRENIA, BASED ON THE POLYMORPHISM RS4680 | |||||||||||||
Medical condition: Esquizofrenia crónica controlada. (10 pacientes con el genotipo val/val y 10 pacientes con el genotipo met/met) | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Restarted) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-000659-11 | Sponsor Protocol Number: GLPG3970-CL-210 | Start Date*: 2020-09-10 | |||||||||||
Sponsor Name:Galapagos NV | |||||||||||||
Full Title: A randomized, double-blind, placebo-controlled, multicenter study to evaluate the safety, tolerability, efficacy, and pharmacokinetics of GLPG3970, administered orally for 6 weeks in adult subjects... | |||||||||||||
Medical condition: Ulcerative Colitis | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: PL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-008713-20 | Sponsor Protocol Number: BGC20-1531-04 | Start Date*: 2009-03-26 |
Sponsor Name:Danish Headache Center | ||
Full Title: EP4 receptor antagonism and PGE2 in a human headache model | ||
Medical condition: PGE2 will induce headache in healthy subjects and BGC20-1531 or placebo will be used to block the developement of headache. In the future BGC20-1531 might be a possible anti-migraine drug. | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DK (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2021-005493-25 | Sponsor Protocol Number: EFISS | Start Date*: Information not available in EudraCT | |||||||||||
Sponsor Name:Fakultní nemocnice Brno | |||||||||||||
Full Title: Effect of Prophylactic Fibrinogen Concentrate In Scoliosis Surgery: A randomized pilot study (EFISS trial) | |||||||||||||
Medical condition: Scoliosis | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-000133-13 | Sponsor Protocol Number: 2020-01131 | Start Date*: 2022-05-05 | |||||||||||
Sponsor Name:Universitätsmedizin Göttingen | |||||||||||||
Full Title: Glucocorticoid enhancement of food exposure therapy in Binge Eating Disorder | |||||||||||||
Medical condition: Binge-Eating-Disorder | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-023362-44 | Sponsor Protocol Number: ITAC 2 | Start Date*: 2010-11-11 |
Sponsor Name:Institute of oncology Ljubljana | ||
Full Title: ITAC 2 TRIAL: INTERMITTENT TKI AND CHEMOTHERAPY FOR PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER | ||
Medical condition: The study population consists of patients aged 18 years and older who have histologicaly or cytologicaly proven locally advanced or metastatic NSCLC with activating mutation of EGFR, chemonaive and... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SI (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2009-013702-14 | Sponsor Protocol Number: BETNV009 | Start Date*: 2010-08-13 | ||||||||||||||||
Sponsor Name:Hospital of the University of Munich | ||||||||||||||||||
Full Title: Effects of betahistine on central vestibular compensation in acute unilateral vestibular failure: a double-blind, placebo-controlled trial | ||||||||||||||||||
Medical condition: vestibular failure (vestibular neuritis) | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2010-024175-58 | Sponsor Protocol Number: kardioIKEM2010 | Start Date*: 2011-06-30 | ||||||||||||||||
Sponsor Name:IKEM | ||||||||||||||||||
Full Title: Comparison of two treatment options for hypertension in heart transplant recipients | ||||||||||||||||||
Medical condition: Compensation of arterial hypertension in heart transplant recipients. Renal function and its changes in heart transplant recipients. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: CZ (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-003715-94 | Sponsor Protocol Number: IDEAL | Start Date*: 2020-12-17 |
Sponsor Name:Institute for Clinical and Experimental Medicine | ||
Full Title: INSULIN THERAPY DE-INTENSIFICATION WITH iGlarLixi | ||
Medical condition: Type 2 diabetes mellitus | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: CZ (Completed) HU (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2018-003831-31 | Sponsor Protocol Number: MS1819/18/02 | Start Date*: 2019-03-28 | |||||||||||
Sponsor Name:AzurRx | |||||||||||||
Full Title: A multicenter, open-label Phase 2 study with escalating doses of MS1819-SD on top of a stable dose of PPEs, to investigate the efficacy and safety of this combination for the compensation of severe... | |||||||||||||
Medical condition: Exocrine Pancreatic Insufficiency | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) ES (Prematurely Ended) PL (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-002373-56 | Sponsor Protocol Number: | Start Date*: 2012-10-02 | |||||||||||
Sponsor Name:Medical Research Council | |||||||||||||
Full Title: PRe-exposure Option for reducing HIV in the UK: an open-label randomisation to immediate or Deferred daily Truvada for HIV negative gay men | |||||||||||||
Medical condition: HIV infection | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-023099-13 | Sponsor Protocol Number: V00251 ST 201 1A | Start Date*: 2011-01-31 | |||||||||||
Sponsor Name:PIERRE FABRE MEDICAMENT -IRPF- PIERRE FABRE INNOVATION | |||||||||||||
Full Title: V0251 oral suspension efficacy and tolerance in vestibular neuritis. A randomised double-blind placebo controlled study | |||||||||||||
Medical condition: The aim of this exploratory study is to assess the efficacy of the L-enantiomer V0251 oral form in the treatment of acute episodes of vertigo. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) CZ (Completed) ES (Completed) DE (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-004229-10 | Sponsor Protocol Number: CCSSMC000766 | Start Date*: 2019-07-19 | |||||||||||
Sponsor Name:McNeil AB | |||||||||||||
Full Title: DOUBLE-BLIND, PLACEBO CONTROLLED STUDY OF PHARMACODYNAMIC EFFECTS OF 4 MG NICOTINE GUM. A STUDY IN HEALTHY SMOKERS WILLING TO QUIT | |||||||||||||
Medical condition: Healthy Volunteers between 19 and 60 years of age motivated and willing to quit smoking. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: PL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-004602-86 | Sponsor Protocol Number: | Start Date*: 2005-11-21 |
Sponsor Name:Medical University of Vienna | ||
Full Title: A comparison of crystalloids vs. colloids for intraoperative goal-directed fluid management | ||
Medical condition: Fluid optimization has been considered as major contributor to improved oxygen delivery, and thus improved outcome in patients. Hypovolemia has been associated with significant increases in morbid... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2008-006788-35 | Sponsor Protocol Number: 0818D1521 | Start Date*: 2009-01-14 | |||||||||||
Sponsor Name:Shionogi & Co., Ltd. | |||||||||||||
Full Title: A randomised, double-blind, placebo-controlled, 2-period crossover study to evaluate effects of multiple oral doses of S-555739 on nasal allergen challenge in subjects with intermittent grass polle... | |||||||||||||
Medical condition: Allergic rhinitis | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
